does va cover semaglutide for weight loss Fairfax OZEMPIC and the VA :

Heterogeneity in the analyses vs active comparators could be attributed to differences in efficacy between the two GLP-1 RAs comparators (dulaglutide and semaglutide) or to differences in background glucose-lowering therapy between the two trials with basal insulin

10.1016/j.mtbio.2025.102053 176

Gulinac M, Miteva DG, Peshevska-Sekulovska M, Novakov IP, Antovic S, Peruhova M, et al

The SURMOUNT-1 trial specifically noted that participants with a BMI of 35 or higher who received the 15mg tirzepatide dose lost an average of 26.5% of their body weight, substantially higher than the overall trial average

Assessment of reduced glutathione According to [19], the reduced glutathione (GSH) level was evaluated using Biodiagnostic kits (Egypt)